Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MRP-L36 Inhibitors

MRP-L36 Inhibitors are a collection of compounds that, by interfering with mitochondrial ribosomal function, indirectly reduce the activity of the mitochondrial ribosomal protein L36 (MRP-L36). These inhibitors include a range of substances that primarily target bacterial ribosomes. Due to the bacterial origin of mitochondria and the structural similarity between bacterial and mitochondrial ribosomes, these compounds can inadvertently affect mitochondrial protein synthesis. The action of such inhibitors results in decreased synthesis of mitochondrial proteins, of which MRP-L36 is a crucial component. This inhibition can lead to a general dysfunction of the mitochondrial ribosomal machinery, thereby impacting the protein translation process within mitochondria where MRP-L36 performs its role. Compounds that bind to the bacterial ribosome's 30S or 50S subunits can, by extension, potentially inhibit mitochondrial ribosomes due to their structural similarities. This results in a perturbation of the protein synthesis process, which is essential for the assembly and function of the mitochondrial ribosome where MRP-L36 is localized. Some of these inhibitors interfere with the elongation phase of protein synthesis, while others block the initiation or translocation steps. The inhibition of these steps can lead to a diminished production of mitochondrial proteins, thereby reducing the functional activity of MRP-L36. As MRP-L36 is involved in the assembly and function of the mitochondrial ribosome, disruption of its activity can have wide-ranging effects on mitochondrial protein synthesis and overall mitochondrial function.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

This compound inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thus preventing the elongation of the polypeptide chain. This would lead to a reduction in the synthesis of MRP-L36 as it directly inhibits the function of the ribosome.

Chloramphenicol

56-75-7sc-3594
25 g
$53.00
10
(1)

Binds to bacterial ribosomes and inhibits protein synthesis. In mitochondria, which have ribosomes similar to bacteria, chloramphenicol can inhibit mitochondrial protein synthesis, thus potentially decreasing the production of MRP-L36.

Erythromycin

114-07-8sc-204742
sc-204742A
sc-204742B
sc-204742C
5 g
25 g
100 g
1 kg
$56.00
$240.00
$815.00
$1305.00
4
(3)

Can bind to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis. Through its action on mitochondrial ribosomes, erythromycin can inhibit the synthesis of mitochondrial proteins, potentially leading to a decrease in MRP-L36 levels.

Tetracycline

60-54-8sc-205858
sc-205858A
sc-205858B
sc-205858C
sc-205858D
10 g
25 g
100 g
500 g
1 kg
$62.00
$92.00
$265.00
$409.00
$622.00
6
(1)

It binds to the 30S subunit of the bacterial ribosome, preventing attachment of aminoacyl-tRNA to the ribosomal acceptor (A) site, inhibiting protein synthesis. As mitochondria have similar ribosomes to bacteria, tetracycline could inhibit the synthesis of mitochondrial proteins like MRP-L36.

Actinonin

13434-13-4sc-201289
sc-201289B
5 mg
10 mg
$160.00
$319.00
3
(1)

Acts as a peptide deformylase inhibitor. It inhibits the removal of N-formyl groups from nascent proteins, which is a critical step in bacterial and mitochondrial protein synthesis. This could lead to decreased synthesis of MRP-L36 by inhibiting its maturation process in the mitochondria.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA. Its effects on mitochondrial translation could lead to a reduction in the production of MRP-L36 by prematurely terminating its synthesis.

Doxycycline-d6

564-25-0 unlabeledsc-218274
1 mg
$16500.00
(0)

Inhibits protein synthesis by binding to the 30S ribosomal subunit, blocking the binding of aminoacyl-tRNA to the A site of the ribosome. This action could decrease mitochondrial protein synthesis, subsequently reducing the production of MRP-L36.

Azithromycin

83905-01-5sc-254949
sc-254949A
sc-254949B
sc-254949C
sc-254949D
25 mg
50 mg
500 mg
1 g
5 g
$51.00
$101.00
$255.00
$357.00
$714.00
17
(1)

Binds to the 50S ribosomal subunit, inhibiting mRNA translation. Its activity can extend to mitochondrial ribosomes, potentially reducing the production of MRP-L36.

Tigecycline

220620-09-7sc-394197
sc-394197A
5 mg
25 mg
$186.00
$439.00
1
(1)

A glycylcycline related to the tetracyclines. It inhibits protein synthesis by binding to the 30S ribosomal subunit and blocking entry of aminoacyl-tRNA molecules into the A site of the ribosome. This may affect mitochondrial protein synthesis and thus reduce the production of MRP-L36.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

This compound inhibits peptide chain elongation by specifically interfering with peptidyl transferase activity on ribosomes. Since this activity is crucial for protein synthesis, anisomycin's action would lead to a decrease in the synthesis of mitochondrial proteins, including MRP-L36, by disrupting mitochondrial ribosome function.